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To the Editor: In a recent commentary related to our paper
on the performance of a risk score questionnaire for
predicting future diabetes [1], Wareham and Griffin make
an interesting point about the effect of real life response
rates on the true performance of a risk assessment [2]. In
our paper we evaluated the performance of the original
Finnish diabetes risk questionnaire to predict future
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screen-detected and clinically diagnosed diabetes. We
demonstrated that the performance of the risk score could
be improved by adding information on sex, smoking and
family history of diabetes [1]. In their commentary,
Wareham and Griffin argue that non-response to a
questionnaire should be taken into account when evalu-
ating the performance of such a risk questionnaire. They
state that when a risk questionnaire is posted out in real
life, response rates may be only 50%, and the true
sensitivity of the presented score would not be 76% but
rather 38%. They go on to suggest that response rates
can be improved to nearly 100% by using risk scores
that are based on data contained in general practice
databases, as has been done in the UK [3, 4], because
they do not require collection of new data. They compare
this with the 50% response rate for risk score question-
naires reported in the Anglo–Danish–Dutch Study of
Intensive Treatment in People with Screen Detected
Diabetes in Primary Care (ADDITION)–Denmark Study
[5], but do not acknowledge that higher response rates
have been achieved—for example 78% in the Hoorn
Screening study [6].
The estimated 100% response rate suggested to be
reached by using data from general practice databases
ignores several important limitations to using these
databases for calculating the risk of diabetes. Missing
or inconsistently recorded information is a major problem
when using databases. Although in the UK these general
practice records have an impressively large amount of
recorded data, information on all risk score items is
required for calculation of a risk score. Body mass index
has been reported to be recorded in approximately 75%
of all persons [4], but information on other risk factors is
required in addition to complete most risk scores. One
solution to the problem of missing data is to remove one or
more items from originally well-performing risk scores
[7]. Ignoring risk score items that have a large proportion
of missing data or data that are inconsistently recorded
will reduce the predictive ability of a risk score and would
need re-validation and calibration of the score. Another
solution is to tag the person with missing data for
opportunistic recording of the missing data at a later visit
[7]. The effectiveness of this approach is unknown, but
will not reach people who do not visit their general
practitioner regularly. Furthermore, risk factors change
over time and general practice information will need to be
regularly updated. Another major barrier is that globally
most healthcare systems do not have computerised
primary practice and thus the capacity for central calcu-
lation of a risk score. For all these reasons the response
rate will be well short of the 100% suggested by Wareham
and Griffin even in situations where this method is an
option.
In step-wise screening programmes, loss to follow-up is
not only confined to the risk assessment step, irrespective
of whether the risk score tool requires completion of a new
form or is populated by data contained in a database, but
also to when high-risk individuals are invited for further
testing, for example (random) glucose measurement. In this
second step, roughly similar response rates have been
reported for those identified by self-report questionnaire or
those identified in general practice records. Documented
response rates vary from 77% in the ADDITION–Denmark
trial [5] to 87% in the Hoorn Screening Study in the
Netherlands [6] for those identified by self-assessed risk
compared with 74% for those identified by general practice
information [7].
There are a number of important considerations when
screening for high risk of future diabetes in order to
implement preventive interventions. Our paper focussed
on the performance of the risk tool and we have shown
that predictive ability of an existing popular risk tool can
be improved with minor modifications. The commentary
by Wareham and Griffin is a valuable reminder to take
non-response in public health programmes seriously.
Dealing with non-response is a major challenge in
prevention programmes. It is critical that risk assessment
has widespread reach to the target population. Many
factors influence this process and further effort and
research is required to maximise individual and commu-
nity participation. Using information from general prac-
tice records is one approach, but is not the universal
answer to this problem. The solution is not a choice
between axes or spades but rather the use of both sharp
axes and good spades.
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